NCT00771147View on ClinicalTrials.gov

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

June 30, 2008

Study Completion Date

November 30, 2010

Conditions
Carcinoma, Renal CellCarcinoma, Renal Cell (Advanced)
Interventions
DRUG

Sorafenib (Nexavar, BAY43-9006)

Patients with diagnosis of advanced renal cell cancer and decision taken by the investigator to prescribe Nexavar®.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY